Clinical evaluation of commercial automated SARS-CoV-2 immunoassays

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays

Objective: Numerous immunoassays for detecting antibodies directed against SARS-CoV-2 have been rapidly developed and released. Validations of these have been performed with a limited number of samples. The lack of standardisation might lead to significantly different results. This study compared te...

Full description

Bibliographic Details
Main Authors: Maximilian Kittel, Maria Christina Muth, Ingrid Zahn, Heinz-Jürgen Roth, Margot Thiaucourt, Catharina Gerhards, Verena Haselmann, Michael Neumaier, Peter Findeisen
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Subjects:
Automated SARS-CoV-2 antibody detection
High throughpu testing
Pandemic control
Serpprevalence
Seroconversion
Longitudional monitoring of antibody development
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220325261

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220325261

Similar Items